CBRECBRE GROUP, INC.Large cap · $40.42B · FY ending 2025-12-31
$138.03-1.08% · 2026-07-13 · EOD
42/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality43
narrow moat · ROIC 12%Value58
P/E 35.9 · 29% of 12-mo rangeMomentum44
death · price below 200-daySmart Money25
selling · 2 funds · 0P/3S insidersMixed trendDeath crossBelow 200-day
vs S&P 500-25.5%
6-mo excess Trailing performance1M +3.0%
3M -2.3%
6M -16.8%
YTD -13.8%
1Y -2.3%
P/E vs its last 12 months (our price history): 32.4 low → 44.6 high
Current price sits at the 29th percentile of that window — near the bottom (cheaper). We only compare against the price history we own (no paid multi-year multiples — nothing invented).
Narrow moat — ROIC 12%
Piotroski F5/9
fundamental strength Altman ZSafe
bankruptcy zone ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of 20%. Annual figures from SEC XBRL.
Dividend & capital return
Shareholder yield2.4%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Net selling0P / 3S insiders · 2 funds hold · 0 Congress buys
Recent insidersGiamartino Emma E. · CFO & Chief Investment OfficerSELL$294,165
Doellinger Chad J · Chief Legal & Admin. OfficerSELL$15,017
Doellinger Chad J · Chief Legal & Admin. OfficerSELL$77,970
Fund holders (13F)ValueAct$31.8M0.6% of book
Third Avenue Management$18.5M3.0% of book
Bhealth · 71/100
Self-fundingSelf-funding — profitable · generates cash
No red flags from its filings.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.